Rankings
▼
Calendar
HOWL Q1 2023 Earnings — Werewolf Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
HOWL
Werewolf Therapeutics, Inc.
$35M
Q1 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$4M
Gross Profit
$4M
100.0% margin
Operating Income
-$12M
-273.8% margin
Net Income
-$12M
-268.4% margin
EPS (Diluted)
$-0.34
QoQ Revenue Growth
-38.7%
Cash Flow
Operating Cash Flow
-$10M
Free Cash Flow
-$10M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$195M
Total Liabilities
$74M
Stockholders' Equity
$121M
Cash & Equivalents
$148M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$4M
$0
—
Gross Profit
$4M
$0
—
Operating Income
-$12M
-$15M
+20.5%
Net Income
-$12M
-$15M
+21.9%
← FY 2023
All Quarters
Q2 2023 →